CN101831717B - Electrostatic spinning device - Google Patents
Electrostatic spinning device Download PDFInfo
- Publication number
- CN101831717B CN101831717B CN2010101308647A CN201010130864A CN101831717B CN 101831717 B CN101831717 B CN 101831717B CN 2010101308647 A CN2010101308647 A CN 2010101308647A CN 201010130864 A CN201010130864 A CN 201010130864A CN 101831717 B CN101831717 B CN 101831717B
- Authority
- CN
- China
- Prior art keywords
- spinning
- fluid reservoir
- fiber
- solution
- dressing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000010041 electrostatic spinning Methods 0.000 title claims abstract description 44
- 239000000835 fiber Substances 0.000 claims abstract description 134
- 238000009987 spinning Methods 0.000 claims abstract description 77
- 239000007788 liquid Substances 0.000 claims abstract description 56
- 239000012530 fluid Substances 0.000 claims description 70
- 230000008859 change Effects 0.000 claims description 4
- 238000005507 spraying Methods 0.000 claims description 4
- 238000002156 mixing Methods 0.000 claims description 3
- 229920000642 polymer Polymers 0.000 abstract description 48
- 150000001875 compounds Chemical class 0.000 abstract description 10
- 238000003860 storage Methods 0.000 abstract description 6
- WABPQHHGFIMREM-UHFFFAOYSA-N lead(0) Chemical compound [Pb] WABPQHHGFIMREM-UHFFFAOYSA-N 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 79
- 229920001610 polycaprolactone Polymers 0.000 description 51
- 239000004632 polycaprolactone Substances 0.000 description 51
- 238000002360 preparation method Methods 0.000 description 45
- 206010052428 Wound Diseases 0.000 description 44
- 208000027418 Wounds and injury Diseases 0.000 description 44
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 40
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 30
- 239000000203 mixture Substances 0.000 description 29
- 229920002873 Polyethylenimine Polymers 0.000 description 20
- 239000003795 chemical substances by application Substances 0.000 description 19
- 239000010410 layer Substances 0.000 description 19
- 239000000463 material Substances 0.000 description 19
- 229920002125 Sokalan® Polymers 0.000 description 18
- 238000000034 method Methods 0.000 description 18
- 239000002904 solvent Substances 0.000 description 17
- 229920000615 alginic acid Polymers 0.000 description 16
- 235000010443 alginic acid Nutrition 0.000 description 16
- 229920001477 hydrophilic polymer Polymers 0.000 description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 13
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 description 12
- 230000005684 electric field Effects 0.000 description 11
- -1 polyoxyethylene Polymers 0.000 description 11
- NNJVILVZKWQKPM-UHFFFAOYSA-N Lidocaine Chemical compound CCN(CC)CC(=O)NC1=C(C)C=CC=C1C NNJVILVZKWQKPM-UHFFFAOYSA-N 0.000 description 10
- 229960004194 lidocaine Drugs 0.000 description 10
- 230000008569 process Effects 0.000 description 10
- 239000000783 alginic acid Substances 0.000 description 9
- 229960001126 alginic acid Drugs 0.000 description 9
- 150000004781 alginic acids Chemical class 0.000 description 9
- 239000004744 fabric Substances 0.000 description 9
- 238000006116 polymerization reaction Methods 0.000 description 8
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 7
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 7
- 229940072056 alginate Drugs 0.000 description 7
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 7
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 7
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 7
- 229920002818 (Hydroxyethyl)methacrylate Polymers 0.000 description 6
- 239000000975 dye Substances 0.000 description 6
- 229960003276 erythromycin Drugs 0.000 description 6
- 229920001600 hydrophobic polymer Polymers 0.000 description 6
- 239000011259 mixed solution Substances 0.000 description 6
- 238000011160 research Methods 0.000 description 6
- 239000004698 Polyethylene Substances 0.000 description 5
- 230000008901 benefit Effects 0.000 description 5
- 230000015572 biosynthetic process Effects 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 150000003949 imides Chemical class 0.000 description 5
- 239000002245 particle Substances 0.000 description 5
- 229920000573 polyethylene Polymers 0.000 description 5
- 239000000725 suspension Substances 0.000 description 5
- 230000010148 water-pollination Effects 0.000 description 5
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 4
- 229920001503 Glucan Polymers 0.000 description 4
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 4
- 239000002250 absorbent Substances 0.000 description 4
- 239000000654 additive Substances 0.000 description 4
- 239000001913 cellulose Substances 0.000 description 4
- 229920002678 cellulose Polymers 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 238000009938 salting Methods 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- NYEZZYQZRQDLEH-UHFFFAOYSA-N 2-ethyl-4,5-dihydro-1,3-oxazole Chemical compound CCC1=NCCO1 NYEZZYQZRQDLEH-UHFFFAOYSA-N 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 230000003115 biocidal effect Effects 0.000 description 3
- 239000004020 conductor Substances 0.000 description 3
- 230000008021 deposition Effects 0.000 description 3
- 238000004090 dissolution Methods 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 239000002121 nanofiber Substances 0.000 description 3
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000000996 additive effect Effects 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 239000012984 antibiotic solution Substances 0.000 description 2
- 239000003899 bactericide agent Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 229920001577 copolymer Polymers 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000005213 imbibition Methods 0.000 description 2
- 239000004745 nonwoven fabric Substances 0.000 description 2
- 239000008363 phosphate buffer Substances 0.000 description 2
- 229920001983 poloxamer Polymers 0.000 description 2
- 229920001992 poloxamer 407 Polymers 0.000 description 2
- 229920000728 polyester Polymers 0.000 description 2
- 229920005594 polymer fiber Polymers 0.000 description 2
- 238000012805 post-processing Methods 0.000 description 2
- 239000011241 protective layer Substances 0.000 description 2
- 238000007711 solidification Methods 0.000 description 2
- 230000008023 solidification Effects 0.000 description 2
- 239000004753 textile Substances 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- 206010039203 Road traffic accident Diseases 0.000 description 1
- 206010039509 Scab Diseases 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 239000003125 aqueous solvent Substances 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 239000000022 bacteriostatic agent Substances 0.000 description 1
- 238000005452 bending Methods 0.000 description 1
- 239000003519 biomedical and dental material Substances 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000003431 cross linking reagent Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 238000001523 electrospinning Methods 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000007380 fibre production Methods 0.000 description 1
- 239000002657 fibrous material Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000002346 layers by function Substances 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 238000007151 ring opening polymerisation reaction Methods 0.000 description 1
- 239000011435 rock Substances 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 238000006748 scratching Methods 0.000 description 1
- 230000002393 scratching effect Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000004381 surface treatment Methods 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 239000002982 water resistant material Substances 0.000 description 1
- 238000009941 weaving Methods 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
- PAPBSGBWRJIAAV-UHFFFAOYSA-N ε-Caprolactone Chemical group O=C1CCCCCO1 PAPBSGBWRJIAAV-UHFFFAOYSA-N 0.000 description 1
Images
Landscapes
- Artificial Filaments (AREA)
- Spinning Methods And Devices For Manufacturing Artificial Fibers (AREA)
Abstract
The invention discloses an electrostatic spinning device, comprising a liquid storage pot, a power supply and a spinning device, wherein, the liquid storage pot is provided with a liquid inlet and a liquid outlet, the power supply is connected with the liquid storage pot by a circuit, the spinning device is communicated with the liquid outlet of the liquid storage pot, and the anode of the power supply is connected with the liquid storage pot and the spinning device by a lead wire. The device can take a wound as a receiving device while preparing polymer electrospun fiber by electrostatic spinning and directly forms a film on the wound to obtain a medical compound; and the obtained compound can be directly applied to the surface of the wound and stably covers the wound.
Description
Technical field
The present invention relates to adopt electrostatic spinning technique to prepare the polymer electrospun fibers technical field, be specifically related to a kind of polymer electrospun device.
Background technology
Electrostatic spinning technique has had some patent reports and breadboard research.In the electrostatic spinning process process, at first make liquid surface form an electric field, when electric field force acts on liquid surface, will produce charged liquid jet at liquid surface.The material that liquid jet can be had opposite charges and have a suitable potential attracts and is stretched.In the process that liquid jet is stretched, will be dried and solidify, generate fiber.Perhaps the liquid jet that is stretched is solidified and drying through the cooling of liquid, the physical solidification such as evaporation of solvent through chemosetting.The fiber that generates is collected by suitable that lay an and receiving system that have a reversed charge, and can from gathering-device, fiber be removed when needed, perhaps can directly apply to the target with reversed charge and generate the zone.
Fiber through above-mentioned prepared all has application in a lot of fields.United States Patent (USP) 4043331 and the 4878908 non-woven fibre dressing with preparation are used for wound dressing.The main advantage that electrospun fibers is applied to wound dressing is can prepare to generate diameter between 50 nanometers to 255 micron or the superfine fibre of more excellent diameter between 50 nanometers to 5 micron.This fiber can be collected and be prepared into the adhesive-bonded fabric dressing of arbitrary shape thickness.Because this fiber has minimum diameter, have minimum space and high unit mass surface area by the fiber dressing of its preparation, this two attributes is the key factor of decision fiber dressing porosity.
The non-woven fabrics fiber dressing that adopts polymer manufacture is applied to wound dressing, has according to the difference of use polymer type and different plurality of advantages.Can use hydrophilic polymers, such as polyurethane, or use non-hydrophily, or slight hydrophobic polymer, such as saturated polyester prepares fiber dressing.By the wound dressing of hydrophilic polymer preparation, blood or blood plasma are easy to penetrate dressing, and higher surface area has been quickened the incrustation process simultaneously.This dressing can be applied to the hemostasis in the first-aid dressing.And,, that is to say that tissue fluid comprises that blood will can not penetrate dressing if interfibrous space is enough little less than 100 microns by the fiber dressing that non-hydrophilic polymer prepares.Therefore, tissue fluid will be fitted with the wound all the time, thereby form a scab.In dressing removal process, what also can become because of the blood clot that does not have infiltration to come in the dressing materials is very convenient.And United States Patent (USP) 4043331 and 4878908 is pointed out this dressing owing to have sufficiently high porosity, and oxygen and steam are exchanged at atmosphere and wound surface.
Except the fiber that can produce the preparation multiple diameter and thus the adhesive-bonded fabric dressing of difformity, thickness, the porosity of prepared, electrostatic spinning technique can prepare equally and differently form, the fiber of synsedimentary concentration and different intrinsic bending strength not.Also mention in the above-mentioned United States Patent (USP), can improve its character through adhesive-bonded fabric dressing being carried out post processing with other materials.For example, can improve the intensity of dressing, thereby also can use silica gel or other water-resistant materials that it is carried out the resistance to water that post processing improves dressing through a kind of suitable bonding.
Through changing the composition of electrospun fibers, can obtain the fiber of different physicochemical properties.This can realize that every kind of component of being added can make product have a kind of specific ideal performance through in spinning solution, adding various ingredients; Also can pass through from the spinning of plurality of raw materials liquid, thereby make the fiber that contains heterogeneity deposit formation dressing simultaneously, the dressing of formation has also just comprised the fiber of different materials.The another kind of method of in patent, mentioning can prepare every layer of multilayer dressing that contains different materials (or fibrous material of the same race, heterogeneity), can the kind of deposit fiber realizes on gathering-device through changing successively.For example, hydrophily can provide different advantageous properties, hydrophilic polymer can provide high absorbance to have weak relatively intensity in different application with non-hydrophilic polymer, though non-hydrophilic polymer absorbability is low, but intensity is better.For example medical in some applications wrapping hopes to combine hydrophily and non-hydrophilic polymer layer in identical product.In this type used, the hydrophilic polymers layer can improve absorbability, and non-hydrophilic polymer layer can provide high relatively intensity simultaneously.But use this laminar structure that a shortcoming is arranged; Be that hydrophobic layer can form obstruction to liquid; Thereby hinder the absorption of hydrophilic layer to liquid; And along with the suction of hydrophilic layer, hydrophilic polymer can lose its three-dimensional structure gradually, breaks away or the integrality of the destruction product that comes off of genetic horizon thereby cause squinting.
Through electrostatic spinning technique, the liquid that contains different component or predecessor is carried out spinning can prepare the adhesive-bonded fabric dressing that contains different fibers, these fibers are collected in a gathering-device that suitable electric field arranged.Adhesive-bonded fabric dressing will form at the gathering-device place, and can transform and combine with other existing materials, the dressing and the wound dressing nexine of desirable properties can be provided of for example weaving.When preparation wound dressing material, textile fabric dressing can be used as support with the wrapping bottom, also can adhesion wrapping material and wound.Simultaneously, it also can provide other advantageous properties to the wrapping material, and for example, the dressing that contains textile fabric can have character fungi-proofing or the promotion wound healing.Adhesive-bonded fabric dressing to having prepared carries out surface treatment, also can make it have other advantageous properties.
In PCT patent WO98/03267, prepared the wound dressing material that on wound, directly carries out electrostatic spinning.In this application, health itself is just as the gatherer of spinning.This method can solution and some problems in preparation and storage such as bandage, gauze in preparation wound dressing material.For example, gauze and bandage must be stored in the aseptic environments could provide protection to wound, if these gauze bandages are not in an aseptic environments, then its protection to wound does not just have effect.Through to the direct electrostatic spinning in the wound of sterile liquid, can effectively address this problem.The direct electrostatic spinning technique in wound has very big restriction to the kind of spinning solution, only with the material of use and skin or other tissue compatibles.For example water, ethanol, acetone.Same, because available solvent species has a lot of restrictions, the kind of additive, for example absorbent, bactericide, antibiotic also receive a lot of restrictions.As a same reason, polymer also receive and skin and tissue compatible solvent between deliquescent restriction.The combination of bioavailable polymer and solvent; For example: polymine and ethanol, polyvinylpyrrolidone and ethanol, poly-hydroxyethyl methacrylate and ethanol, polyoxyethylene and water etc.; Fiber that above combined preparation goes out and wound or external environment condition do not have reactivity, can make its pH become acid or alkalescence according to the composition of fiber by neutrality.For example: will participate in protolysis when polymine is exposed in the liquid, and can make the liquid that contacts with polymer partly become alkalescence.
Can find out that from the above research of mentioning electrostatic spinning is included in preparation formation liquid jet in the electric field, jet solidifies or is dried in stretching in the moving process of target.The fiber that produces fundamental property deposition at random according to diffusion.Thereby this has just caused material outside the target area, can produce certain deposition having caused waste.Simultaneously, because fiber can be by electric field attracts and at the part preferential deposition of wound near electrospinning device,, fiber scratching or the depths of other wounds effectively deposits so can being hindered by electric field.Meanwhile, curing or dry speed also depend on the factors such as stretching mobile route of liquid jet, and these all can have influence on the physical property of the non-woven fabrics fiber of preparing.
Therefore, the non-woven fibre dressing firm with other and suction of wound dressing material still has very big research needs.Through bioavailable polymer and other polymer that can reach appropriate pH are carried out electrostatic spinning, preparation non-woven fibre wound dressing also has very big research space simultaneously.The non-woven fibre dressing of other kinds still can keep the plurality of advantages of electrospun fibers, and having equally needs research to prepare medical cloth through electrostatic spinning process or other non-woven fibre dressing is used for the method and apparatus in field separately.Need study the electrostatic spinning preparation method and the equipment of the nanofiber that contains additive simultaneously, and solidification rate how to control electrospun fibers, thereby control is by the non-woven fibre dressing of electrospun fibers preparation and the character of film.
Summary of the invention
The invention provides a kind of firm and have an absorbefacient polymer electrospun fibers of good fluid, with and preparation method thereof.
It is medical fibre dressing that the present invention also provides a kind of medical compound that utilizes polymer electrospun fibers to prepare, and can be used to treat wound and/or protect the wounded not contaminated.
The present invention also provides a kind of electrostatic spinning apparatus; Be used for electrostatic spinning and prepare polymer electrospun fibers; And can the polymer electrospun fibers of preparation be directly applied to wound surface, the medical compound that covers wound and have different sizes and shape that formation can be stable.
A kind of polymer electrospun fibers comprises following component by mass percent:
PH regulator agent 0-20%;
Described polymer is hydrophilic polymer and/or slight hydrophobic polymer.
Described polymer generally may be dissolved in and forms polymer-dicyandiamide solution in the solvent, is used further to prepare electrospun fibers, and solvent can volatilize away in the process of preparation.
Described solvent can be selected the organic solvent or the aqueous solvent that can dissolve required polymer for use, even solvent harmful to wound but that can in the preparation process before the wound contacting, vapor away (being that volatility is good) also can be selected for use.Choice of Solvent can be confirmed according to the dissolution properties of polymer, generally selects solubility property solvent preferably, can select in ethanol, acetone, water, oxolane or other the low-molecular-weight alcohols etc. one or more for use.
As preferably:
Described hydrophilic polymer can select linear polyethylene imines (L-PEI or LPEI), poly-hydroxyethyl methacrylate (Poly-HEMA), polyvinylpyrrolidone (PVP) for use, gather in ethyl oxazoline (PEOz), the polyoxyethylene (PEO) one or more.
Described slight hydrophobic polymer can be selected polycaprolactone (PCL) for use.PCL is the linear aliphatic adoption ester by caprolactone ring-opening polymerization gained, and it is a kind of half hitch crystal formation macromolecule, at room temperature is rubbery state, its better heat stability, and decomposition temperature is more much higher than other polyester.PCL has good medicine trafficability characteristic and mechanical property, can be used as bio-medical material and drug release material, and PCL and other high molecular compatibility are fine, can prepare the copolymer or the blend of multiple function admirable.
Described pH regulator agent can be selected alginic acid (Alginate) or polyacrylic polymer (trade name carbopol) for use.
According to actual needs; Can also optionally comprise some interpolation components in the described polymer electrospun fibers; These interpolation components are included in the electrospun fibers, can be applied in wound surface through the medical compound that utilizes electrospun fibers to process.Research shows; Add component and not only comprise the interpolation component that in polymer-dicyandiamide solution, to dissolve; Also be included in undissolved interpolation component (can not use) in polymer-dicyandiamide solution, can be included in undissolved particle suspensions in the solvent in promptly described polymer-dicyandiamide solution through separation.For example treat component, can select in antibiotic, bactericide, bacteriostatic agent, crosslinking agent, anodyne and other medicaments one or more for use; Helper component for example can be selected in adhesive, aromatic, the nucleic acid etc. one or more for use; For example can select a kind of in lidocaine, erythromycin, glucan, pluronic, dyestuff, acrylic acid, oligomeric butoxy entprol (oligomeric BE), active carbon, shitosan, the polymine-cellulose etc. for use.
Described interpolation amounts of components can be adjusted according to actual needs, for example, can add according to the consumption of its effective dose for the treatment component.
The preparation method of described polymer electrospun fibers may further comprise the steps:
Polymer is dissolved in forms polymer-dicyandiamide solution in the solvent, selectivity obtains mixed solution after adding the pH regulator agent, makes polymer electrospun fibers through electrostatic spinning.
The mass percentage concentration of polymer is preferably 5%-30% in described polymer-dicyandiamide solution.
The mass percentage concentration of described pH regulator agent in mixed solution is preferably 0-3%.
Can also selectivity add the interpolation component in the described mixed solution; Adding component concentrations in the mixed solution can adjust according to actual needs; Be generally 0-30%, for example when adding treatment component lidocaine or erythromycin, its mass fraction in mixed solution is preferably 2.5%; When adding glucan, its mass fraction in mixed solution is preferably 4%; When adding pluronic, its mass fraction in solution is preferably 15%-25%.
Described interpolation component and solvent for use can be compatible also can be inconsistent.When adding component when incompatible with solvent, the interpolation component can be wrapped in the fiber, and can bring into play its effect and do not change the film layer structure of fiber dressing.
The voltage of described electrostatic spinning is preferably 15KV-25KV, solidifies distance and is preferably 10cm-30cm.
Described polymer electrospun fibers can be used for preparing medical compound, is used to treat wound.
A kind of electrostatic spinning apparatus comprises the fluid reservoir of band inlet and liquid outlet, the power supply that is connected through circuit with fluid reservoir and the device for spinning that is communicated with the fluid reservoir liquid outlet; Described positive source is connected with device for spinning with fluid reservoir through lead.During use, Jiang's power supply gets minus earth, can produce the required electric field of device for spinning, and then the liquid charging stock from the ejection of fluid reservoir liquid outlet is carried out electrostatic spinning.
Described fluid reservoir is used the liquid charging stock required with storing electrostatic spinning.
Described power supply can be selected any battery that is applicable to electrostatic spinning apparatus for use, comprises the lead-acid battery of common 1.5V alkaline battery, high-octane lithium battery or 12V etc.
Described device for spinning in a tubular form, its mouth of pipe has the cap of spraying nozzle that is used to seal.
Be provided with mixing arrangement in the described fluid reservoir, be used for the liquid charging stock in the mixed and dispersed fluid reservoir.It can select agitating device or Vltrasonic device for use, through physical agitation or rock feed liquid is fully mixed, also can make insoluble additives in liquid charging stock, form homogeneous suspension liquid.
Described fluid reservoir, power supply and device for spinning all are arranged in dismountable outer cover, so that keep safety operation.
Described electrostatic spinning apparatus also comprises the gathering unit that fiber is concentrated on the target area; The mouth of pipe of surface thereof and device for spinning is relative; Can agree with the electrostatic spinning apparatus support; But and need not to be completely fixed on the device, can dismantle and move relative to the mouth of pipe of device for spinning, with near or away from the mouth of pipe of device for spinning.
This gathering unit can be the tabular electric conductor of ground connection, also can be wounded's wound surface.Its principle is thereby that gathering unit or wounded's health ground connection are reached zero potential, between itself and fluid reservoir, has just produced the required electric field of electrostatic spinning like this.
Described outer cover extends an adjusting device that device for spinning is moved, and is used to change the interval in device for spinning and intended application zone.
Single or a pair of feet is extended in the adjusting device bottom, is used for supporting device for spinning and makes it and wound keeps certain distance in use, so just can before fiber touches skin, have sufficient time to drying.
Spike extends to form a protection shell to its inside, to be used to protect device for spinning, prevents that it from being contacted.
For can the simultaneously continuous different types of fiber of preparation; Described fluid reservoir can be arranged to a plurality of as required; Also baffle plate can be set in fluid reservoir, fluid reservoir inside is separated into a not connected cavity arbitrarily, and each cavity be communicated with device for spinning all.
During concrete the use, can use one of them fluid reservoir to prepare fibrage separately and also can use each fluid reservoir simultaneously.
The big I of described electrostatic spinning apparatus is provided with according to actual needs voluntarily; Preferably can the spatial relation of its each parts be carried out reasonably optimizing; To design the enough little device that can reach hand-held degree, so just can, the wounded directly utilize this device to prepare fiber dressing in the wound before being transported treatment, in time the wounded are given treatment to; Can be widely used in the situation that battlefield or other wounded are difficult to betransported, such as the stranded situation of the wounded in the traffic accident.
The present invention has following advantage:
The existing fiber of polymer electrospun fibers of the present invention is firm and have the better fluid absorbability, has wide range of applications.Its preparation method is simple to operate, can adjust according to actual needs, is suitable for suitability for industrialized production.
Medical compound of the present invention or fiber dressing can directly be used to treat wound and/or protection the wounded is not contaminated.Compare with traditional dressing, have and remove conveniently, can alleviate the painful advantage of the wounded.
Electrostatic spinning apparatus of the present invention can be when electrostatic spinning prepares polymer electrospun fibers, with wound as receiving device; Direct film forming on wound; The medical compound of preparation, the compound that makes can directly apply to wound surface, and the stable wound that covers.
Electrostatic spinning apparatus of the present invention can also optionally be skipped intermediate steps device (being tabular gathering unit), directly carries out the collection and the application of electrospun fibers in the wound surface of three-dimensional, and is more convenient.
Electrostatic spinning apparatus of the present invention can be connected to human body with the earth terminal of its power supply, thereby attracts charged fiber, thereby the fiber that makes is directly applied to the wound.
Electrostatic spinning apparatus of the present invention can prepare at least a polymer fiber, can also produce multiple desirable fiber through the preparation of multiple functional layer in the electrostatic spinning process as required.For example, can prepare and comprise the fibrage that helps the drug material, also can prepare the fibrous outer that comprises high concentration antibiotic or organization restoration medicine and make it bring into play effect in wound surface.Simultaneously also can make fiber dressing nexine comprise the fiber that high-absorbable is provided, and fiber dressing skin include the fiber of resistance to water.
Description of drawings
Fig. 1 is the structural representation of portable electrostatic device for spinning of the present invention; Wherein, F represents electrospun fibers among the figure, and W represents wound surface;
Fig. 2 is the structural representation of fluid reservoir in the portable electrostatic device for spinning of the present invention;
Fig. 3 is the structural representation of another kind of fluid reservoir in the portable electrostatic device for spinning of the present invention;
Fig. 4 is electrospun fibers dressing and the comparison diagram that contains the water absorptivity (being the liquid-absorbent rate) of the electrospun fibers dressing of hydrophilic polymer layer, hydrophobic polymer layer, pH regulator agent layer by the composition polymer preparation;
Fig. 5 is by the electrospun fibers dressing of composition polymer preparation and the comparison diagram of the equilibrium moisture content of the electrospun fibers dressing that contains hydrophilic polymer layer, hydrophobic polymer layer, pH regulator agent layer.
The specific embodiment
As shown in Figure 1; Portable electrostatic device for spinning 1 of the present invention; Battery pack 5 that comprises the fluid reservoir 3 of band inlet and liquid outlet, is connected through circuit with fluid reservoir 3 and the device for spinning in a tubular form 2 that is communicated with fluid reservoir 3 liquid outlets, its mouth of pipe has the cap of spraying nozzle 13 that is used to seal.
The inlet of fluid reservoir 3 is through valve 12 controls.
The battery pack 5 anodal leads 7 that pass through are connected with device for spinning 2 with fluid reservoir 3.During use, Jiang's battery pack 5 minus earths turn on the power switch and just can produce the required electric field of device for spinning 2, and then the liquid charging stock 4 from the ejection of fluid reservoir 3 liquid outlets is carried out electrostatic spinning.
Be provided with agitating device 6 in the fluid reservoir 3, be used for the liquid charging stock 4 in the mixed and dispersed fluid reservoir 3.
Fluid reservoir 3, battery pack 5 and device for spinning 2 all are arranged in dismountable outer cover 9, so that keep safety operation, extended bayonet socket 11 is connected on outer cover 9 and the fluid reservoir 3.
Electrostatic spinning apparatus 1 also comprises the gathering unit that fiber is concentrated on the target area; The mouth of pipe of surface thereof and device for spinning 2 is relative; Can agree with electrostatic spinning apparatus 1 support; But and need not to be completely fixed on the device 1, can dismantle and move relative to the mouth of pipe of device for spinning 2, with near or away from the mouth of pipe of device for spinning 2.
This gathering unit can be the tabular electric conductor of ground connection, also can be wounded's wound surface W.Its principle is thereby that gathering unit or wounded's health ground connection are reached zero potential, between itself and fluid reservoir 3, has just produced the required electric field of electrostatic spinning like this.
Outer cover 9 extends an adjusting device that device for spinning 2 is moved, and is used to change device for spinning 2 and the regional interval of intended application.
A pair of feet 10 is extended in the adjusting device bottom, is used for supporting device for spinning 2 and makes it and wound keeps certain distance in use, so just can before fiber touches skin, have sufficient time to drying.
Fluid reservoir 3 can be arranged to a plurality of, and is as shown in Figure 2: fluid reservoir 52a, fluid reservoir 52b, fluid reservoir 52c and fluid reservoir 52d, and they all are positioned at outer cover 9, and pass through the user mode of switch 54 each fluid reservoirs of control, and it can use separately or use simultaneously; Switch 54 is connecting battery pack 5 through lead 56.Each fluid reservoir can be equipped with a kind of polymer, and this just can the simultaneously continuous different types of fiber of preparation.For example, fluid reservoir 52a is equipped with the solution that good absorption property can be provided, and fluid reservoir 52b is equipped with and contains antibiotic solution, and fluid reservoir 52c is equipped with the solution that is used to prepare fiber dressing internal layer, and fluid reservoir 52d is equipped with the solution of preparation fiber dressing outside protective layer.Can use one of them fluid reservoir to prepare fibrage separately and also can use each fluid reservoir simultaneously.
Another kind of embodiment is for being provided with baffle plate in fluid reservoir 3; Fluid reservoir 3 inside are separated into an arbitrarily not connected cavity, and each cavity is communicated with device for spinning 2 all, as shown in Figure 3; Fluid reservoir 17a, fluid reservoir 17b, fluid reservoir 17c and fluid reservoir 17d; They all are positioned at outer cover 9, and pass through the user mode of switch 18 each fluid reservoirs of control, and it can use separately or use simultaneously; Switch 18 is connecting battery pack 5 through lead 19.Each fluid reservoir can be equipped with a kind of polymer, and this just can the simultaneously continuous different types of fiber of preparation.For example, fluid reservoir 17a is equipped with the solution that good absorption property can be provided, and fluid reservoir 17b is equipped with and contains antibiotic solution, and fluid reservoir 17c is equipped with the solution that is used to prepare fiber dressing internal layer, and fluid reservoir 17d is equipped with the solution of preparation fiber dressing outside protective layer.Can use one of them fluid reservoir to prepare fibrage separately and also can use each fluid reservoir simultaneously.
Portable electrostatic device for spinning 1 of the present invention is when concrete the use; At first remove outer cover 9 so that fluid reservoir 3 is operated through bayonet socket 11; Required liquid charging stock is prepared the back inject device for spinning 2 immediately, can make insoluble additives in feed liquid, form homogeneous suspension liquid through agitating device 6 through inlet.Fluid reservoir 3 can clean the back and reuse, and also can disposablely use.
The earth terminal 8 of battery pack 5 is passed through lead 14 ground connection 15; Turn on the power switch and take off cap of spraying nozzle 13; This moment, liquid charging stock 4 promptly can expose, and formed nanofiber thereby electric field force solidifies liquid charging stock 4 in device for spinning 2 liquid outlets form jet and moving, and finally was deposited on the wound W.This moment, fiber will be attracted through the wound surface of lead 14 ground connection or the electric conductor 15 of other ground connection.In this case, the electrostatic spinning apparatus 1 and the wounded's health all is in state electrical ground, and the wounded also can hold the handle of electrostatic spinning apparatus 1 to reach same effect.
Embodiment 1
Use contains the fiber production medical dressing of polycaprolactone and/or linear polyethylene imines.
Polycaprolactone is dissolved in the solution that acetone is prepared into 18% (w/w).The linear polyethylene imines is dissolved in the solution that ethanol preparation becomes 25% (w/w).Sample is become by above-mentioned solution mixing system.And use multiple pH regulator agent.When using alginic acid or Carbopol; Its mass fraction in two kinds of polymer (polycaprolactone/linear polyethylene imines) be 2.9% or its concentration in polymer solution (polycaprolactone/linear polyethylene imines) be that 2.9% (w/w) is in order to mix the pH regulator agent; At first alginic acid is dissolved in small amount of ethanol; Then add the linear polyethylene imide liquor, add polycaprolactone solution at last.Final mixture is carried out spinning immediately through above-mentioned electrostatic spinning apparatus 1, and to avoid the gathering of pH regulator agent, making medical compound is fiber dressing.When using Carbopol, at first Carbopol is dissolved in small amount of acetone, then add polycaprolactone solution, add the linear polyethylene imide liquor at last.Final mixture is carried out spinning immediately, to avoid the gathering of pH regulator agent.
In order to measure its water imbibition, cutting area is 1.5cm
2Fiber dressing and its dry weight of weighing.Then fiber dressing is drained liquid dry and weighing (weight in wet base) behind water-soluble or salting liquid (pH=7) certain hour.
Calculating formula is:
Sample 1: separately to the polycaprolactone solvent spinning.Polycaprolactone is dissolved in the solution that acetone is prepared into 18% (w/w), at room temperature, uses the voltage of 23KV and the curing distance of 17.8cm that it is carried out spinning, prepare the firm white fiber about 1 μ m.
Sample 2: the polycaprolactone solution to adding pH regulator agent Carbopol carries out spinning.Polycaprolactone is dissolved in the Carbopol that acetone is prepared into the solution of 18% (w/w) and is mixed into 2.9% (w/w), at room temperature, uses the voltage of 24KV and the curing distance of 19.1cm that it is carried out spinning, prepare the firm white fiber about 1 μ m.
Sample 3: the polycaprolactone solution to adding pH regulator agent alginic acid carries out spinning.Polycaprolactone is dissolved in the alginic acid that acetone is prepared into the solution of 18% (w/w) and is mixed into 2.9% (w/w), at room temperature, uses the voltage of 15KV and the curing distance of 16.5cm that it is carried out spinning, prepare the firm white fiber about 1 μ m.
Sample 4: separately to the spinning of linear polyethylene imide liquor.The linear polyethylene imines is dissolved in the solution that ethanol preparation becomes 18% (w/w), at room temperature, uses the voltage of 23KV and the curing distance of 17.8cm that it is carried out spinning, prepare firm white fiber less than 1 μ m.
Sample 5: the linear polyethylene imide liquor to adding pH regulator agent Carbopol carries out spinning.The linear polyethylene imines is dissolved in the Carbopol that ethanol preparation becomes the solution of 25% (w/w) and is mixed into 2.9% (w/w), at room temperature, uses the voltage of 19KV and the curing distance of 15.2cm that it is carried out spinning, prepare firm white fiber less than 1 μ m.
Sample 6: the linear polyethylene imide liquor to adding pH regulator agent alginic acid carries out spinning.The linear polyethylene imines is dissolved in the alginic acid that ethanol preparation becomes the solution of 25% (w/w) and is mixed into 2.9% (w/w), at room temperature, uses the voltage of 15KV and the curing distance of 17.8cm that it is carried out spinning, prepare firm white fiber less than 1 μ m.
Sample 7: linear polyethylene imines and polycaprolactone blend solution to not adding the pH regulator agent carry out spinning.The linear polyethylene imines is dissolved in the solution that ethanol preparation becomes 25% (w/w); Polycaprolactone is dissolved in the solution that acetone is prepared into 18% (w/w); Mix two kinds of solution with 20: 80 mass ratioes; At room temperature, use the voltage of 15KV and the curing distance of 17.8cm that it is carried out spinning, prepare firm white fiber smaller or equal to 1 μ m.
Sample 8: linear polyethylene imines and polycaprolactone blend solution to adding pH regulator agent Carbopol carry out spinning.The linear polyethylene imines is dissolved in the solution that ethanol preparation becomes 25% (w/w); Polycaprolactone is dissolved in the solution that acetone is prepared into 18% (w/w); Mix two kinds of solution with 20: 80 mass ratioes, add the Carbopol of 2.9% (w/w) again, at room temperature; Use the voltage of 15KV and the curing distance of 12.7cm that it is carried out spinning, prepare firm white fiber smaller or equal to 1 μ m.
Sample 9: linear polyethylene imines and polycaprolactone blend solution to adding pH regulator agent alginic acid carry out spinning.The linear polyethylene imines is dissolved in the solution that ethanol preparation becomes 25% (w/w); Polycaprolactone is dissolved in the solution that acetone is prepared into 18% (w/w); Mix two kinds of solution with 20: 80 mass ratioes, add the alginic acid of 2.9% (w/w) again, at room temperature; Use the voltage of 23KV and the curing distance of 19.1cm that it is carried out spinning, prepare firm white fiber smaller or equal to 1 μ m.
The firm white fiber of sample 1-9 is processed fiber dressing respectively, and measure pH their Effect on Performance and their water imbibition.The result sees table 1, table 2 and Fig. 3, Fig. 4.Equilibrium moisture content that it should be noted that fiber dressing is different with the equilibrium moisture content of single fiber, because the surface tension between the fiber is greater than single fiber in fiber dressing.
Table 1
Table 2
| Sample | Fibrous | The equilibrium moisture content of fiber dressing (percentage) |
| 4 | LPEI | 92.72 |
| 5 | LPEI+Carbopol | 94.67 |
| 6 | LPEI+Alginate | 94.50 |
| 1 | PCL | 71.29 |
| 2 | PCL+Carbopol | 81.94 |
| 3 | PCL+Alginate | 91.65 |
| 8 | LPEI+PCL+Carbopol | 95.03 |
| 9 | LPEI+PCL+Alginate | 93.85 |
| 7 | LPEI+PCL | 87.32 |
Table 1 has been listed sample soaks liquid after 24 hours in salting liquid (being the phosphate buffer of pH=7) and water pH value.From data, can find out, in hydrophily linear polyethylene imines (LPEI), add the pH regulator agent and can make the water and the salting liquid that soak fiber approaching more neutral.
Because polycaprolactone does not have linear polyethylene imines hydrophily strong (can find out from equilibrium moisture content), so the pH difference of water behind the immersion fiber and salting liquid changes not obvious.
Table 2 has been listed the equilibrium moisture content of different fibers after 24 hours.Can find out that from data the fiber that consists of LPEI+PCL+Carbopol, LPEI+PCL+Alginate has approximate equilibrium moisture content with the fiber that consists of LPEI, LPEI+Carbopol, LPEI+Alginate.
Fig. 3 and Fig. 4 described by the electrospun fibers dressing of the different composition polymers of forming (PCL/LPEI, sample 8:PCL/LPEI/C.P (being Carbopol), sample 9:PCL/LPEI/ALG.A (being Alginate)) preparation respectively in one minute (1M), one hour (1H), one day (1D) and four days (4D) to the uptake of water and phosphate buffer, and it liquid-absorbent rate with the electrospun fibers dressing that contains hydrophilic polymer layer, hydrophobic polymer layer, pH regulator agent layer (PCL/LPEI/ALG.A/PCL) compared.
Fig. 3 has shown to be compared with the dressing of stratiform fiber by the electrospun fibers dressing of composition polymer (PCL/LPEI/C.P, PCL/LPEI/ALG.A) preparation to have higher liquid-absorbent rate.
Fig. 4 has shown that the equilibrium moisture content of composite polymer fibers dressing also is higher than the dressing of stratiform fiber.
Embodiment 2
Through in material liquid, adding the therapeutic component, be the feedstock production fiber with multiple composition polymer solution.
Preparation polycaprolactone (PCL) solution; Poly-hydroxyethyl methacrylate (Poly-HEMA) solution, polyvinylpyrrolidone (PVP) solution, Ju ethyl oxazoline (PEOz) solution; Polyoxyethylene (PEO) solution; And linear polyethylene imines (L-PEI) solution, through adding different therapeutic components therein, form multiple composition polymer solution with the preparation fiber.
During preparation polycaprolactone (PCL) solution; At first in beaker, add 12.29g polycaprolactone (PCL) and 50g acetone; Heating is until dissolving; After the polymer dissolution, solution is stirred and be cooled to room temperature, then in sample, add acetone and make the mass percentage concentration of polycaprolactone (PCL) in acetone reach 16%.
Preparation Ju ethyl oxazoline (PEOz); Polyoxyethylene (PEO); Take during polyvinylpyrrolidone (PVP) solution and prepare the identical step of polycaprolactone (PCL) solution; The 9.10g polymer is added in the lidded container, then add the required solvent of 47.77g, be prepared into the polymer quality percentage concentration and be 16% solution.
During preparation linear polyethylene imines (L-PEI) solution, 5g linear polyethylene imines (L-PEI) is dissolved in 20g ethanol, is prepared into the L-PEI mass percentage concentration and is 20% solution.
During preparation poly-hydroxyethyl methacrylate (Poly-HEMA); At first in beaker, add 7.07g poly-hydroxyethyl methacrylate (Poly-HEMA) and 38.39g ethanol; Be heated to dissolving; In course of dissolution, add the 1.25g Glycolic acid that is dissolved in 2.02g ethanol, the solution that obtains contains the poly-hydroxyethyl methacrylate of the Glycolic acid and 15% (w/w) of 5.5% (w/w).
Sample 10: it is 23% solution that lidocaine is added in the ethanol preparation lidocaine mass percentage concentration, then it is added in the above-mentioned various polymerization thing solution, makes that the lidocaine quality percentage composition in the product fiber is 2.5%.
Sample to containing lidocaine carries out the lidocaine release experiment.Mixture is carried out spinning under the curing distance of the voltage of 18KV and 26cm, prepare the fiber of diameter at 400-700nm.
Sample 11: lidocaine is dissolved in ethanol and solution has been placed Waterlock 180 (trade names; It is a kind of superhigh hydroscopicity polymer, and it is the acrylamide/acrylates copolymer that obtains through hydrolyzed starch-acrylonitrile grafting polymer) culture dish in.With ethanol evaporation; The gained particle is added in the above-mentioned various polymerization thing solution; Mixture is carried out spinning under the curing distance of the voltage of 21.0KV and 20cm, prepare the fiber of diameter 1 μ m, make that the lidocaine quality percentage composition in the product fiber is 2.5%.The release property experiment of sample shows that Waterlock 180 has slowed down the release of lidocaine from non-woven nanofiber dressing.
Sample 12: 0.1g erythromycin is added dissolving in the 0.31g acetone, and to be prepared into the erythromycin mass percentage concentration be 24% solution.Then erythromycin solution is added in the above-mentioned various polymerization thing solution, mixture is carried out spinning under the curing distance of the voltage of 19.9KV and 20cm, prepare the fiber of diameter 1-2 μ m.In the fiber of preparing, the mass fraction of erythromycin is 2.5%.
Sample 13: glucan is dissolved in the deionized water and adds in the above-mentioned various polymerization thing solution, and the mass fraction of glucan is 4%, and mixture is carried out spinning under the curing distance of the voltage of 17.2KV and 20cm, prepares the fiber of diameter 400-600nm.
Sample 14: it is the solution of 20%-35% that spirit soluble dyestuff is dissolved in the ethanol preparation dyestuff mass percentage concentration, and it is added in linear polyethylene imines (L-PEI) solution.Preparation dyestuff mass percentage concentration is the dye solution of 20%-35%, it is added in the above-mentioned various polymerization thing solution, with mixture the curing of the voltage of 17KV and 23cm apart under carry out spinning, prepare the fiber of diameter 1-2 μ m.In the fiber of preparing, the mass fraction of dyestuff is 1.2%-5.4%.
Sample 15: in above-mentioned various polymerization thing solution, add adhesive-acrylic emulsion and oligomeric BE (oligomeric butoxy entprol), solution is carried out spinning under the curing distance of the voltage of 16.5KV and 25cm, prepare the fiber of diameter 1 μ m.In the fiber of preparing, acrylic acid mass fraction is 1.5%, and oligomeric BE mass percentage concentration is 1.5%.
Sample 16: pluronic F127 is dissolved in acetone soln and joins in the above-mentioned various polymerization thing solution.The mass percentage concentration of pluronic F127 in polycaprolactone (PCL) is 15%-25%.Under the curing distance of the voltage of 17.5KV and 30cm, carry out spinning, prepare the fiber of diameter 1-2 μ m.
Sample 17, sample 18, sample 19, sample 20 and sample 21 are respectively: Carbopol, active carbon, Waterlock180, shitosan, polymine-cellulose (PEI-cellulose) are added in the above-mentioned various polymerization thing solution with the form of solid respectively form suspension.Their concentration changes with the size of particle and the different of concentration of polymer solution.Under the curing distance of the voltage of 21KV and 20cm, carry out spinning, prepare the fiber of diameter 1-2 μ m.In the fiber of preparing, the Carbopol mass percentage concentration is that 2.5%-3.5%, quality of activated carbon percentage concentration are that 1.2%-5.4%, Waterlock180 mass percentage concentration are that 2%-3.5%, chitosan mass percentage concentration are that 4.2%-5.5%, polymine-cellulose quality percentage concentration are 2%-2.5%.
For promoting the dispersion of particle, solve the not good problem of solution suspension, in the solvent spinning process, use a dispersion that the electric agitator promotion particle of 10cm glass stirring rod is arranged.
Sample 10-21 compares with embodiment 1, and outstanding is the composition difference of fiber dressing, promptly in material liquid, adds other helper components such as therapeutic, is the feedstock production fiber with multiple composition polymer solution.Special equipment described in the literary composition is fit to through variety classes composition polymer formulations prepared from solutions fiber more; Among Fig. 2 and Fig. 3 in specifically described 4 material liquid tanks; Just can add and contain the polymer solution that different therapeutic are added components, thus different fibrolaminar difference in functionalitys in the formulated product as required.
Claims (2)
1. electrostatic spinning apparatus comprises the fluid reservoir of band inlet and liquid outlet, the power supply that is connected through circuit with fluid reservoir and the device for spinning that is communicated with the fluid reservoir liquid outlet;
Described positive source is connected with device for spinning with fluid reservoir through lead;
Described device for spinning in a tubular form, its mouth of pipe has the cap of spraying nozzle that is used to seal;
Be provided with mixing arrangement in the described fluid reservoir;
Described fluid reservoir, power supply and device for spinning all are arranged in dismountable outer cover;
Described electrostatic spinning apparatus also comprises the gathering unit that fiber is concentrated on the target area;
Described outer cover extends an adjusting device that device for spinning is moved, and is used to change the interval in device for spinning and intended application zone;
Single or a pair of feet is extended in described adjusting device bottom;
Described spike extends to form a protection shell to its inside, to be used to protect device for spinning;
Described fluid reservoir is provided with baffle plate, fluid reservoir inside is separated into a not connected cavity arbitrarily, and each cavity is communicated with device for spinning all.
2. electrostatic spinning apparatus as claimed in claim 1 is characterized in that, described fluid reservoir has four.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010101308647A CN101831717B (en) | 2010-03-23 | 2010-03-23 | Electrostatic spinning device |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010101308647A CN101831717B (en) | 2010-03-23 | 2010-03-23 | Electrostatic spinning device |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101831717A CN101831717A (en) | 2010-09-15 |
| CN101831717B true CN101831717B (en) | 2012-03-28 |
Family
ID=42715927
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2010101308647A Expired - Fee Related CN101831717B (en) | 2010-03-23 | 2010-03-23 | Electrostatic spinning device |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101831717B (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102340002B (en) * | 2011-08-29 | 2014-03-12 | 长春理工大学 | Lithium iron phosphate nanofiber as lithium ion battery cathode material and preparation method thereof |
| CN107687028A (en) * | 2017-09-28 | 2018-02-13 | 华南协同创新研究院 | A kind of Electrospun nano-fibers facial mask preparation method and preparing instrument |
| CN108403296B (en) * | 2018-02-11 | 2020-12-18 | 郑州大学 | Double-sided opposite-nature adhesive bandage based on electrostatic spinning process and manufacturing method thereof |
| EP3884089A4 (en) | 2018-11-19 | 2023-04-05 | Octet Medical, Inc. | Device, systems, and methods of applying a treatment solution to a treatment site |
| CN109537068B (en) * | 2018-12-19 | 2021-08-06 | 上海固甲新材料科技有限公司 | Liquid jet spinning device |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6753454B1 (en) * | 1999-10-08 | 2004-06-22 | The University Of Akron | Electrospun fibers and an apparatus therefor |
| CN1327912C (en) * | 2005-08-11 | 2007-07-25 | 浙江大学 | Catheter stent preparation method for repairing tubular tissue and organ and apparatus thereof |
-
2010
- 2010-03-23 CN CN2010101308647A patent/CN101831717B/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN101831717A (en) | 2010-09-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101805940A (en) | Polymer electrospun fibers, preparation method thereof and application thereof | |
| US6753454B1 (en) | Electrospun fibers and an apparatus therefor | |
| CN101831717B (en) | Electrostatic spinning device | |
| US9468700B2 (en) | Wound dressings with enhanced gas permeation and other beneficial properties | |
| CA2386810C (en) | Electrospun skin masks and uses thereof | |
| CN106390177B (en) | Chitosan-based multilayer nanofiber membrane dressing and preparation method and application thereof | |
| Li et al. | Silver nanoparticle/chitosan oligosaccharide/poly (vinyl alcohol) nanofibers as wound dressings: a preclinical study | |
| CN105268015A (en) | Antibacterial hydrogel composite material and preparation method thereof | |
| Wei et al. | The multifunctional wound dressing with core–shell structured fibers prepared by coaxial electrospinning | |
| US20060153904A1 (en) | Non-woven fiber assemblies | |
| CN104703507A (en) | Cosmetic sheet formed from nanofiber with controlled dissolution velocity and method for manufacturing same | |
| CN104162184B (en) | A kind of based composite dressing for medical use and its preparation method | |
| CN104958779B (en) | A kind of wound dressing containing chelating silver fiber | |
| CN102319448A (en) | Antibacterial aquagel material for preparing medical wound dressing and preparation method thereof | |
| CN104548188B (en) | Hyaluronic acid-nano silver-based dressing and preparation method thereof | |
| CN106166305A (en) | A kind of broad-spectrum antiseptic type wound care film and preparation method thereof | |
| CN102813562A (en) | Three-dimensional large-aperture nanoscale fibrous scaffold and method for preparing same | |
| CN104874010A (en) | Composite zinc silver antibacterial agent contained chitosan fiber dressing and preparation method thereof | |
| Oraby et al. | Electrospinning of Gelatin Functionalized with Silver Na-noparticles for Nanofiber Fabrication | |
| CN105999361B (en) | A kind of medical dressing and preparation method thereof with intelligent delivery of antimicrobials ability | |
| Li et al. | Construction of porous structure-based carboxymethyl chitosan/sodium alginate/tea polyphenols for wound dressing | |
| CN102199809A (en) | Medical dressing and preparation method thereof | |
| CN113634048A (en) | Natural silk micro-nano fiber composite porous material and application thereof | |
| CN108135861A (en) | Dry type is pasted | |
| WO2019056819A1 (en) | Collagen-loaded alginate medical dressing and preparation method therefor |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20120328 Termination date: 20150323 |
|
| EXPY | Termination of patent right or utility model |